# Scientist I, Bioanalytical – Drug Antibody Conjugates (DACs) at Nurix AI

- Company: Nurix AI
- What the company does: AI agents that run your enterprise workflows and get measurably better over time. 150+ enterprises live in production across retail, insurance, and financial services. Backed by Accel and General Catalyst.
- Company website: https://www.nurix.ai/
- Type: Startups (AI role)
- Level: Mid level
- Location: Brisbane, California
- Work setup: On-site
- Pay: $124K to $143K base salary per year (USD)
- Posted: 2026-08-05
- Apply by: 2026-10-08
- Apply: https://job-boards.greenhouse.io/nurix/jobs/8684692002
- Page: https://www.1752.vc/careers/jobs/nurix-ai-scientist-i-bioanalytical-drug-antibody-conjugates-dacs/

## About the role

Nurix Therapeutics is seeking a Scientist to lead bioanalytical strategies supporting the discovery and development of next-generation degrader antibody conjugates (DACs). This role will focus on LC-MS/MS and hybrid assay strategies for quantitative and qualitative analysis of complex bioconjugates across in vitro and in vivo studies to understand DAC pharmacokinetics, pharmacodynamics, and biotransformation.

## What they're looking for

- Ph.D. with 5+ years or M.S. with 8+ years of relevant industry experience in Bioanalysis, Analytical chemistry, or related field
- Deep expertise in LC-MS/MS bioanalysis, including method development, qualification/validation, and troubleshooting for complex modalities
- Proven experience with Sciex platforms (e.g., 7600 ZenoTOF, 6500+, 7500) and high-resolution MS
- Strong background in ADCs, DACs, or related bioconjugates, including characterization and payload quantitation
- Experience supporting both in vitro ADME and in vivo PK studies, with demonstrated ability to interpret integrated datasets
- Proficiency in sample preparation techniques for large molecules and bioconjugates (e.g., immunocapture, enzymatic digestion, hybrid workflows)

Tags: DMPK